Traditional Chinese medicine preparation for curing benign prostatic hyperplasia

Abstract

The invention provides a traditional Chinese medicine preparation for curing benign prostatic hyperplasia. Active ingredients of the preparation are prepared from the following raw materials according to weight ratio: 10-15 of radix glehniae, 9-12 of caesalpinia, 10-15 of light red Tuckahoe, 10-15 of root of common peony, 3-6 of radix glycyrrhizae preparata, 10-20 of raw rehmannia, 5-10 of plantain seed, 10-15 of liriope, 3-10 of inula lineariifolia turcz, 6-15 of cortex lycii radicis, and 10-15 of grilled astragalus. The dosage form of the prepared medicine is one of oral liquid, capsule, troche, pill and powder. The preparation disclosed by the invention not only can be used for tonifying Qi, clearing away the heart-fire, circulating heart and kidney, smoothing kidney water, enhancing bladder systolic function, promoting reduced volume of prostate and effectively relieving bladder outlet obstruction symptoms, but also can be used for coordinating balanced action on human blood and physiological function of the five internal organs (a heart, a liver, a spleen, lungs and kidneys), conditioning qi activity and achieving the purposes of treating disease from the root; furthermore, the preparation has the advantages of being light in dosage, accurate in curative effect, short in treatment course, high in cure rate, low in operation curing probability, low in side effect, and the like.

Description

technical field

[0001] The invention relates to a traditional Chinese medicine preparation, in particular to a traditional Chinese medicine preparation for treating benign prostatic hyperplasia accompanied by lower urinary tract obstruction symptoms, which is suitable for treating senile benign prostatic hyperplasia. Background technique

[0002] Prostatic hyperplasia is a special pathological change of prostatic stroma and / or glandular hyperplasia, leading to benign prostatic enlargement and bladder outlet obstruction. It mostly occurs in male patients over 50 years old, and is the most common cause of voiding disorders in middle-aged and elderly men. A common benign disease. In 1984, Berry et al. summarized 5 groups of autopsy reports from different countries and found that the incidence of histological benign prostatic hyperplasia gradually increased with age. The 50-59 age group is about 40%, the 60-69 age group is about 70%, the 70-79 age group is about 80%, and the 80...

Examples

Embodiment 1

[0013] The prescription and the weight ratio of each component are: Adenophora 12, Echeveria 9, Chi Fu Ling 12, Chi Shao 15, Radix Glycyrrhizae 6, Rehmannia glutinosa 15, Plantago 9, Ophiopogon japonicus 12, Bupleurum 6 , Digupi 12, Sunburned Astragalus 15.

[0014] After weighing the above components by weight, the raw materials are prepared into oral liquid according to the conventional oral liquid production process.

Embodiment 2

[0016] The prescription and the weight ratio of each component are: Adenophora 15, Shilianzi 12, Chi Fu Ling 15, Chi Shao 12, Zhi Licorice 5, Rehmannia glutinosa 12, Plantago 10, Ophiopogon japonicus 12, Bupleurum 6 , Digupi 12, Sunburned Astragalus 15.

[0017] After weighing the above-mentioned components by weight, the raw materials are made into honeyed pills according to the conventional honeyed pill production process.

Embodiment 3

[0019] The prescription and the weight ratio of each component are: Adenophora 15, Shilianzi 10, Chi Fu Ling 12, Chi Shao 115, Zhi Licorice 6, Rehmannia glutinosa 20, Semen Plantaginis 10, Ophiopogon japonicus 15, Bupleurum 9 , Digupi 12, Sunburned Astragalus 12.

[0020] After the above-mentioned components are weighed by weight, the raw materials are made into tablets according to the conventional tablet production process.

technical field

[0001] The invention relates to a traditional Chinese medicine preparation, in particular to a traditional Chinese medicine preparation for treating benign prostatic hyperplasia accompanied by lower urinary tract obstruction symptoms, which is suitable for treating senile benign prostatic hyperplasia. Background technique

[0002] Prostatic hyperplasia is a special pathological change of prostatic stroma and / or glandular hyperplasia, leading to benign prostatic enlargement and bladder outlet obstruction. It mostly occurs in male patients over 50 years old, and is the most common cause of voiding disorders in middle-aged and elderly men. A common benign disease. In 1984, Berry et al. summarized 5 groups of autopsy reports from different countries and found that the incidence of histological benign prostatic hyperplasia gradually increased with age. The 50-59 age group is about 40%, the 60-69 age group is about 70%, the 70-79 age group is about 80%, and the 80...

Examples

Embodiment 1

[0013] The prescription and the weight ratio of each component are: Adenophora 12, Echeveria 9, Chi Fu Ling 12, Chi Shao 15, Radix Glycyrrhizae 6, Rehmannia glutinosa 15, Plantago 9, Ophiopogon japonicus 12, Bupleurum 6 , Digupi 12, Sunburned Astragalus 15.

[0014] After weighing the above components by weight, the raw materials are prepared into oral liquid according to the conventional oral liquid production process.

Embodiment 2

[0016] The prescription and the weight ratio of each component are: Adenophora 15, Shilianzi 12, Chi Fu Ling 15, Chi Shao 12, Zhi Licorice 5, Rehmannia glutinosa 12, Plantago 10, Ophiopogon japonicus 12, Bupleurum 6 , Digupi 12, Sunburned Astragalus 15.

[0017] After weighing the above-mentioned components by weight, the raw materials are made into honeyed pills according to the conventional honeyed pill production process.

Embodiment 3

[0019] The prescription and the weight ratio of each component are: Adenophora 15, Shilianzi 10, Chi Fu Ling 12, Chi Shao 115, Zhi Licorice 6, Rehmannia glutinosa 20, Semen Plantaginis 10, Ophiopogon japonicus 15, Bupleurum 9 , Digupi 12, Sunburned Astragalus 12.

[0020] After the above-mentioned components are weighed by weight, the raw materials are made into tablets according to the conventional tablet production process.